Why Apple (AAPL), Alphabet (GOOG), Pfizer (PFE) and Two Other Stocks are Trending Today
The markets are sliding on Wednesday after a report from Automatic Data Processing, which shows a decline in the growth of private sector employment.
Medivation Inc. (MDVN)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
Why Investors Are Buzzing About These Stocks Today
It's M&A Thursday, as several major M&A deals have been announced today.
Why These Five Stocks Are Deep in Red on Tuesday?
Markets opened lower on Tuesday amid a decline in crude prices that dragged lower many energy stocks.
Investors Can't Get Enough of These 4 Stocks Today
With the S&P 500 and Dow Jones barely in the green as investors remain concerned about China's slowing economy, Big Lots, Inc.
Medivation Inc (MDVN): Are Hedge Funds Right About This Stock?
The equity market returns were very disappointing in the third quarter, “thanks” to the slowdown of China’s economy and the weaker-than-expected U.S. economic data.
Mariner Investment Group's Top Biotech Stock Picks For Q4
Mariner Investment Group is a New York-based investment advisory firm founded by William Michaelcheck in 1992.
These Are Apex Capital Management's Top Biotech Stock Picks
Founded in 1987, Apex Capital Management invests mainly in companies that have market caps of up to $10 billion and is currently overseeing $6.5 billion in assets under management.
AstraZeneca plc (ADR) (AZN), Johnson & Johnson (JNJ): Will the Exelixis, Inc. (EXEL) Hype Catch Up to Its Valuation?
The small patient pool for medullary thyroid cancer, or MTC, isn't going to move the needle for a large pharmaceutical company. But Exelixis, Inc.
Do Hedge Funds and Insiders Love Seattle Genetics, Inc. (SGEN)?
At the moment, there are a multitude of metrics shareholders can use to monitor stocks. A pair of the most useful are hedge fund and insider trading sentiment.
Hedge Fund Bets On Onyx Pharmaceuticals, Inc. (ONXX)
As fast as we can type this, Phill Gross and Robert Atchinson's hedge fund, Adage Capital Partners, disclosed ownership of about 3.7 million shares of Onyx Pharmaceuticals, Inc.
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
